2017 Cancer Research UK Early Diagnosis Research Conference
Tuesday, 13 September 2016 09:56
Registration for the 2017 Cancer Research UK Early Diagnosis Research Conference (formerly NAEDI conference) is now open. The conference will take place on 23rd and 24th February 2017 in central London.
Cancer Research UK's early diagnosis work is made possible thanks to donations from the public. This year, to help cover the costs of the 2017 conference, we are asking delegates to pay a registration fee:
- 1 day rate (23rd February or 24th February): £100.00
- 2 day rate (both 23rd and 24th February): £150.00
Following the 2015 NAEDI Research conference, the 2017 conference aims to bring together researchers, clinicians, patients and policy makers to share and discuss the latest research findings, their impact on policy, and future implications for early diagnosis.
This year's conference will focus on new data and outputs within the following themes:
- Cancer screening
- Patient factors in timely presentation and diagnosis
- Optimising clinical practice and systems
- Risk assessment and risk stratification
- Cancer data to achieve new insights in cancer control
- Health economics
European Society of Gastroenterology and Endoscopy Nurses and Associates Newsletter
Tuesday, 26 April 2016 13:00
Please follow the link below for the latest newsletter from the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA)
Non-Medical Endoscopist Competence Assessment Portfolio
Thursday, 10 December 2015 09:40
This document supports the Skills for Health / Higher Education England Non-Medical Endoscopist career framework by providing a portfolio of evidence for competence achievement. This document is not mandatory for all trainees to complete, but provides a structure and framework document which can be used to evidence their progress and completion of competencies which are specific to NME's within endoscopy.
The role of the Non-Medical Endoscopist is crucial in the delivery of high quality diagnostic and therapeutic endoscopy services. As such, NME's are required to demonstrate critical awareness of knowledge issues in the field of endoscopy and at the interface between different fields. Typically operating at level 7, they are innovative and have a responsibility for developing and changing practice and/or services in a complex and unpredictable environment. The role spans leadership, innovation, excellence and mastery within the individual’s scope of practice, and provides a holistic approach to care for individuals undergoing endoscopy, spanning the journey from initial referral through to discharge and future management. As a consequence, individuals entering into the role MUST be able to demonstrate the necessary level of knowledge, skills and attributes commensurate with that of professionals who have significant experience within the healthcare setting. Such areas include communication skills, infection control, record keeping / documentation etc. The career framework document which outlines the NME role contains within it (page 6) diagrammatic representation of the typical attributes of level 7 roles which should be considered as part of competency development and assessment.
Making reasonable adjustments to cancer screening
Tuesday, 10 November 2015 13:38
Public Health England - update of the 2012 report
Cancer screening programmes have been asked to make reasonable adjustments for people with learning disabilities. This population have been shown to have poorer health and are more likely to die at a younger age than people in the general population, in part because of poor access to health services. People with learning disabilities are at a higher risk of gastrointestinal cancer, improving uptake for bowel cancer screening programmes is needed for this population. The guidance from Public Health England gives useful links to resources to help healthcare providers adjust services to meet the healthcare needs for people with learning disabilities for all the cancer screening programmes in England.
Patient Safety Alert: Naloxone
Friday, 30 October 2015 10:35
Resources to minimise the risk of distress and death from inappropriate doses of naloxone
A Stage One: Warning Alert was issued 20 November 2014 drawing attention to the safety implications of inappropriate doses of the opioid/opiate antagonist naloxone. Whilst naloxone use can be life-saving in respiratory depression and respiratory arrest, the previous Stage One Alert highlighted that use of naloxone in patients where it is not indicated, or in larger than recommended doses, can cause a rapid reversal of the physiological effects for pain control, leading to intense pain and distress, and an increase in sympathetic nervous stimulation and cytokine release precipitating an acute withdrawal syndrome. Hypertension, cardiac arrhythmias, pulmonary oedema and cardiac arrest may result from inappropriate doses of naloxone being used for these types of patients.
- Read full text [ 124 kb ]
Page 1 of 3